Assessment of histamine pharmacodynamics by microvasculature response of histamine using histamine iontophoresis laser doppler flowimetry

Journal of Clinical Pharmacology

Volumn 49, Issue 5, 2009, Pages 600-605

  Jones, Bridgette L ^a,b   Abdel Rahman, Susan M ^a,b   Simon, Steve D ^a,b   Kearns, Gregory L ^a,b   Neville, Kathleen A ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Antihistamines; Histamine; Iontophoresis; Laser Doppler; Skin prick

Indexed keywords

HISTAMINE;

ACCURACY; ADULT; ANALYTIC METHOD; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG RESPONSE; EPICUTANEOUS HISTAMINE TEST; FEMALE; HUMAN; INTERMETHOD COMPARISON; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; MICROVASCULATURE; NORMAL HUMAN; PHARMACODYNAMICS; PRURITUS; SKIN BLOOD VESSEL; URTICARIA;

ADMINISTRATION, CUTANEOUS; BLOOD FLOW VELOCITY; FEMALE; HISTAMINE; HISTAMINE ANTAGONISTS; HUMANS; IONTOPHORESIS; LASER-DOPPLER FLOWMETRY; MALE; MICROVESSELS; SKIN; SKIN TESTS; YOUNG ADULT;

EID: 65549099069     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009332247     Document Type: Article

References (30)

1. Simons FE, McMillan JL, Simons KJ A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol. 1990 ; 86 (pt 1). 540-547. (Pubitemid 20372514)
2. Simons FE, Silver NA, Gu X., Simons KJ Skin concentrations of H1-receptor antagonists. J Allergy Clin Immunol. 2001 ; 107: 526-530. (Pubitemid 32210035)
3. Simons F. H1-Antihistamines: more relevant than ever in the treatment of allergic disorders. J Allergy Clin Immunol. 2003 ; 112: S42 - S52. (Pubitemid 37243976)
4. van Steekelenburg J., Clement PA, Beel MH Comparison of five new antihistamines (H1-receptor antagonists) in patients with allergic rhinitis using nasal provocation studies and skin tests. Allergy. 2002 ; 57: 346-350. (Pubitemid 34280664)
5. Kaliner MA, White MV, Economides A., et al. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression. Ann Allergy Asthma Immunol. 2003 ; 90: 629-634. (Pubitemid 36712670)
6. Pearlman DS, Grossman J., Meltzer E. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2003 ; 91: 258-262. (Pubitemid 37174158)
7. Watson WT, Simons KJ, Chen XY, Simons FE Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol. 1989 ; 84 (pt 1). 457-464. (Pubitemid 19266741)
8. Simons FE, Simons KJ The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med. 1994 ; 330: 1663-1670. (Pubitemid 24166868)
9. Simons F. Advances in H1-antihistamines. N Engl J Med. 2004 ; 351: 2203-2217.
10. Deschamps C., Dubruc C., Mentre F., Rosenzweig P. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model. Clin Pharmacol Ther. 2000 ; 68: 647-657. (Pubitemid 32059991)
11. Simons FE, Simons KJ Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years. J Allergy Clin Immunol. 2005 ; 116: 355-361. (Pubitemid 41096543)
12. Howarth PH, Salagean M., Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy. 2000 ; 55 (suppl 64). 7-16. (Pubitemid 32095164)
13. Magerl W., Westerman RA, Mohner B., Handwerker HO Properties of transdermal histamine iontophoresis: differential effects of season, gender, and body region. J Invest Dermatol. 1990 ; 94: 347-352. (Pubitemid 20061645)
14. Bickel A., Kramer HH, Hilz MJ, Birklein F., Neundorfer B., Schmelz M. Assessment of the neurogenic flare reaction in small-fiber neuropathies. Neurology. 2002 ; 59: 917-919.
15. Birklein F., Claus D., Riedl B., Neundorfer B., Handwerker H. Effects of cutaneous histamine application in patients with sympathetic reflex dystrophy. Muscle Nerve. 1997 ; 20: 1389-1395. (Pubitemid 27446866)
16. Heyer G., Hornstein OP, Handwerker HO Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls. J Invest Dermatol. 1989 ; 93: 492-496. (Pubitemid 19225494)
17. Schuller TB, Hermann K., Baron R. Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy. J Neurol. 2000 ; 247: 267-272. (Pubitemid 30223963)
18. Khan F., Litchfield SJ, Belch JJ Cutaneous microvascular responses are improved after cholesterol-lowering in patients with peripheral vascular disease and hypercholesterolaemia. Adv Exp Med Biol. 1997 ; 428: 49-54. (Pubitemid 28127988)
19. Turkeltaub P. In vivo methods of standardization. Clin Rev Allergy. 1986 ; 4: 371-387.
20. Kubli S., Waeber B., Dalle-Ave A., Feihl F. Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. J Cardiovasc Pharmacol. 2000 ; 36: 640-648.
21. Martin H., Gazelius B., Norman M. Impaired acetylcholine-induced vascular relaxation in low birth weight infants: implications for adult hypertension? Pediatr Res. 2000 ; 47 (pt 1). 457-462. 22. Martin H., Hu J., Gennser G., Norman M. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation. 2000 ; 102: 2739-2744. (Pubitemid 30183219)
22. Veves A., Saouaf R., Donaghue VM, et al. Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes. 1997 ; 46: 1846-1852. (Pubitemid 27456420)
23. Kvandal P., Stefanovska A., Veber M., Kvernmo HD, Kirkeboen KA Regulation of human cutaneous circulation evaluated by laser Doppler flowmetry, iontophoresis, and spectral analysis: importance of nitric oxide and prostaglandines. Microvasc Res. 2003 ; 65: 160-171. (Pubitemid 36438682)
24. Dvorak M., Watkinson A., McGlone F., Rukwied R. Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res. 2003 ; 52: 238-245. (Pubitemid 36791930)
25. Leroy T., Tasset C., Valentin B., Van Neste D. Comparison of the effects of cetirizine and ebastine on the skin response to histamine iontophoresis monitored with laser Doppler flowmetry. Dermatology. 1998 ; 197: 146-151. (Pubitemid 28395842)
26. Thysman S., Van Neste D., Preat V. Noninvasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol. 1995 ; 8: 229-236.
27. Monroe E., Daly A., Shalboub R. Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines. J Allergy Clin Immunol. 1997 ; 99: S798 - S806. (Pubitemid 27091597)
28. Purohit A., Duvernelle C., Melac M., Pauli G., Frossard N. Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Ann Allergy Asthma Immunol. 2001 ; 86: 387-392. (Pubitemid 32332316)
29. Kaliner MA, White MV, Economides A., et al. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression. Ann Allergy Asthma Immunol. 2003 ; 90: 629-634. (Pubitemid 36712670)
30. Clough G., Bennett A., Church M. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. Br J Dermatol. 1998 ; 138: 806-814. (Pubitemid 28231521)